Published Date: 02 Mar 2023
When the arteries supplying blood to the stomach and liver swell and burst, it is an emergency in which 50% of patients die before reaching the hospital. This "silent killer" situation, know...
Read Full NewsWalter Kernan, MD, senior research scientist at Yale University, discussed the latest primary stroke prevention guidelines and their focus on lifelong brain health and risk factor management.
Andy Berkowski, MD, PhD, certified sleep neurologist and author of the RLS guidelines, spoke about the clinical impact of the recently published restless syndrome guidelines.
FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma
Sleep Disorders Linked to Poorer Symptom Control in Severe Asthma
IgA Nephropathy Prediction Model Aids 5-Year Survival Estimation
Increased Physical Activity Linked to Reduced Mortality In Peritoneal Dialysis
GLP-1 RA Use Linked to 42% Hepatocellular Carcinoma Risk Reduction in T2DM
1.
Routine breast cancer screening can bring better outcomes for patients
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC
4.
Testosterone recovery linked to overall survival in high-risk prostate cancer
5.
Skinny melanoma incidence is associated with vitamin D deficiency.
1.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
2.
Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success
3.
Apheresis vs. IVMP in Cancer Treatment: A Tale of Two Titans
4.
Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk
5.
Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
3.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation